AIM: The aim of the study was to investigate the utility of NT-proBNP measurement for the stratification of presurgical cardiac risk. METHODS: Cardiac risk before elective non-cardiac surgery was evaluated in 82 consecutive patients. From each patient a venous blood sample was drawn to determinate NT-proBNP levels. Patients were followed up over three months in order to detect the occurrence of cardiac adverse events. RESULTS: NT-proBNP was positively correlated (P<0.0001) with age, days of hospitalization (P=0.001) and ASA class (P=0.001). High surgical risk (P<0.0001), diabetes (P=0.004), dyslipidemia (P=0.006) and elevated levels of NT-proBNP (P<0.0001) were significantly correlated with events. Using a logistic regression analysis we found an independent association between pre-operative elevated NT-proBNP and postoperative cardiac events (OR 1.2, 95% CI 1.0-1.4, P=0.01). CONCLUSION: Measuring NT-proBNP before non cardiac surgery in clinical practice could be useful to better stratify patients' risk.
AIM: The aim of the study was to investigate the utility of NT-proBNP measurement for the stratification of presurgical cardiac risk. METHODS: Cardiac risk before elective non-cardiac surgery was evaluated in 82 consecutive patients. From each patient a venous blood sample was drawn to determinate NT-proBNP levels. Patients were followed up over three months in order to detect the occurrence of cardiac adverse events. RESULTS: NT-proBNP was positively correlated (P<0.0001) with age, days of hospitalization (P=0.001) and ASA class (P=0.001). High surgical risk (P<0.0001), diabetes (P=0.004), dyslipidemia (P=0.006) and elevated levels of NT-proBNP (P<0.0001) were significantly correlated with events. Using a logistic regression analysis we found an independent association between pre-operative elevated NT-proBNP and postoperative cardiac events (OR 1.2, 95% CI 1.0-1.4, P=0.01). CONCLUSION: Measuring NT-proBNP before non cardiac surgery in clinical practice could be useful to better stratify patients' risk.
Authors: G Cucinella; G Calagna; G Romano; G Di Buono; G Gugliotta; S Saitta; G Adile; M Manzone; G Accardi; A Perino; A Agrusa Journal: G Chir Date: 2016 May-Jun
Authors: A Agrusa; G Romano; G Cucinella; G Cocorullo; S Bonventre; G Salamone; G Di Buono; G De Vita; G Frazzetta; D Chianetta; V Sorce; G Bellanca; G Gulotta Journal: G Chir Date: 2013 Sep-Oct
Authors: Henrik Reinhard; Niels Wiinberg; Peter R Hansen; Andreas Kjær; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen Journal: Cardiovasc Diabetol Date: 2011-08-03 Impact factor: 9.951
Authors: A Agrusa; G Romano; G Salamone; E Orlando; G Di Buono; D Chianetta; V Sorce; L Gulotta; M Galia; G Gulotta Journal: Int J Surg Case Rep Date: 2015-10-13
Authors: Antonino Agrusa; Giuseppe Di Buono; Salvatore Buscemi; Brenda Randisi; Leonardo Gulotta; Vincenzo Sorce; Giuseppe Badalamenti; Domenico Albano; Massimo Galia; Giorgio Romano; Gaspare Gulotta Journal: Int J Surg Case Rep Date: 2019-03-26
Authors: Rodolfo Costa Lobato; Rafael Ferreira Zatz; Wilson Cintra Junior; Miguel Luiz Antonio Modolin; Alex Chi; Yanessa Katiana Van Dunem Filipe de Almeida; Rolf Gemperli Journal: Int J Surg Case Rep Date: 2019-05-14